Experimental studies have demonstrated that oxidation of
|
|
- Julian Thornton
- 5 years ago
- Views:
Transcription
1 Serum Antioxidant Vitamins and Blood Pressure in the United States Population Jing Chen, Jiang He, Lee Hamm, Vecihi Batuman, Paul K. Whelton Abstract Serum vitamin C has been inversely associated with blood pressure in several epidemiologic studies, but little is known about effect of other antioxidant vitamins. We examined the relation between serum vitamins A, C, and E, and -carotene levels and blood pressure among men and women 20 years of age who participated in the Third National Health and Nutrition Examination Survey. Blood pressure was characterized as the average of 6 measurements obtained over 2 visits by trained observers and hypertension was defined as blood pressure 140/ 90 mm Hg and/or taking antihypertensive medications. In multivariate models, a1sddifference in vitamin A (16.2 g/dl) and vitamin E (20.4 g/dl) was associated with a 43% (OR, 1.43; 95% CI, 1.34 to 1.53) and 18% (OR, 1.18; 95% CI, 1.09 to 1.27) higher odds of hypertension, respectively. A1SDdifference in -carotene (0.47 g/dl) and -carotene (496 g/dl) was associated with a 16% (OR, 0.84; 95% CI, 0.76 to 0.94) and 11% (OR, 0.89; 95% CI, 0.82 to 0.97) lower odds of hypertension, respectively. In addition, serum vitamins A and E were positively and significantly associated with both systolic and diastolic blood pressure, whereas -carotene and -carotene were inversely and significantly associated with systolic and vitamin C associated with diastolic blood pressure in multivariate linear regression analyses. These findings indicate that antioxidant vitamins may be important in the underlying cause and prevention of hypertension. Further studies in this important area are warranted. (Hypertension. 2002;40: ) Key Words: blood pressure vitamins epidemiology antioxidants Experimental studies have demonstrated that oxidation of LDL plays an important role in the development and progression of atherosclerosis in animal models. 1 3 Observational epidemiologic studies have also documented an inverse association between increased intake of antioxidant vitamins such as vitamin E, and vitamin C and reduced morbidity and mortality rates from coronary heart disease. 1 6 However, results from several recently published, large, randomized, controlled clinical trials, which provide the best evidence for a causal relation, do not support the hypothesis that vitamin E or -carotene supplementation has a protective effect on coronary heart disease or cardiovascular disease as whole. 7 9 Given the wide use of antioxidant vitamins in the US general population, it is important to examine the beneficial as well as potential adverse effects of vitamin supplementation in this context. Observational epidemiologic studies have suggested an inverse association between dietary intake or serum level of vitamin C and blood pressure (BP) Several small and short-term clinical trials in which the effect of vitamin C supplements on BP was examined have yielded inconsistent findings There are sparse data on the relation between other antioxidant vitamins and BP in human populations We took advantage of a large representative sample of the US general population to examine the relation of serum antioxidant vitamins, including vitamins A, C, and E, and -carotene to BP. We hypothesized that serum levels of antioxidant vitamins might be inversely related to BP levels as well as risk of hypertension. Methods Study Participants The Third National Health and Nutrition Examination Survey (NHANES III) was conducted by the National Center for Health Statistics between 1988 and The details of study participants and study methods have been published elsewhere. 23 In brief, a stratified multistage probability design was used to obtain a representative sample of the civilian noninstitutionalized US general population. 23 The design included oversampling of the very young, the elderly, non-hispanic blacks, and Mexican-Americans to improve the precision of estimates in these groups. A total of persons 20 years of age participated in NHANES III. For the current analysis, participants were excluded if their self-reported race/ethnicity was not non-hispanic white, non-hispanic black, or Mexican-American (n 715). Participants were also excluded from the analysis if there was a lack of data on BP (n 348) or serum antioxidant vitamin levels (n 2445). A total of 6755 non-hispanic whites, 4250 non-hispanic blacks, and 4312 Mexican-Americans 20 years of age met the inclusion criteria and were included in the current analysis. In addition, 2544 participants who were currently taking antihypertensive medications were further excluded from the Received April 8, 2002; first decision May 2, 2002; revision accepted July 2, From the Department of Medicine, Tulane University School of Medicine (J.C., J.H., L.H., V.B., P.K.W), and the Department of Epidemiology, Tulane University School of Public Health and Tropical Medicine (J.H., P.K.W.), New Orleans, La. Correspondence to Dr Jiang He, Department of Epidemiology, Tulane University School of Public Health and Tropical Medicine, 1430 Tulane Ave, SL 18, New Orleans, LA jhe@tulane.edu 2002 American Heart Association, Inc. Hypertension is available at DOI: /01.HYP
2 Chen et al Antioxidant Vitamins and Blood Pressure 811 TABLE 1. Characteristics of the Study Participants by Hypertensive Status Variables Normotensives (n ) Hypertensives (n 4860) P Age, y Male gender, % Non-Hispanic white, % Non-Hispanic black, % High school graduate, % Weekly alcohol drinking, % Self-reported diabetes, % Body mass index, kg/m Systolic blood pressure, mm Hg Diastolic blood pressure, mm Hg Total energy intake, kcal/24 hr Dietary saturated fat intake, % kcal Dietary sodium intake, mg/1000 kcal Dietary potassium intake, mg/1000 kcal Serum vitamin A, g/dl Serum g/dl Serum g/dl Serum vitamin C, mg/dl Serum vitamin E, g/dl Values are mean SE or percentage. linear regression analysis in which BP was used as a dependent variable. Measurements The NHANES III data collection included a standardized home interview followed by a detailed physical examination in a mobile examination center or the participant s home. Information on a wide variety of sociodemographic, medical history, nutritional history, and family history questions, such as self-reported age, race/ethnicity, gender, years of education completed, history of smoking, diabetes, and hypertension, use of antihypertensive medication, alcohol consumption, use of vitamin supplements, and 24-hour dietary recall, were obtained during the home interview. 23 BP was measured 3 times during the home interview and during the subsequent evaluation at the mobile examination center by trained observers using a standard protocol. 23 BP for individual participants was calculated as the average of all available systolic and diastolic readings. Hypertension was defined as the presence of a mean systolic BP 140 mm Hg and/or diastolic BP 90 mm Hg and/or use of antihypertensive medication. Body weight and height were measured according to a standard protocol, and body mass index was calculated as an index for obesity. A blood sample was collected at the second visit. Serum levels of antioxidant vitamins, including vitamin A, vitamin C, and vitamin E were measured at the National Center for Environmental Health of the Centers for Disease Control and Prevention (Atlanta, Ga) by isocratic high-performance liquid chromatography. 24 Statistical Analyses Mean values for age, BP, body mass index, dietary nutrient intake, serum antioxidant vitamins, and other continuous variables, as well as percentages for gender, race/ethnicity, and other categoric variables, were calculated by hypertension status. The statistical significance of differences was examined by means of Student t test (continuous variables) and the 2 test (categoric variables). The agreement between serum level of vitamins and supplement use or dietary intake was assessed by Pearson correlation coefficients (r). Bivariate relations were explored by plotting each serum antioxidant vitamin versus BP, which does not impose any statistical modeling assumptions on the associations. The linearity of the association was tested by means of correlation analysis. Linear regression analysis was used to assess the association between serum antioxidant vitamin levels and BP. Logistic regression analysis was used to explore the relation between serum antioxidant vitamin levels and odds of hypertension. Estimated regression coefficients or odds ratios are reported as the difference in BP (mm Hg) or odds of hypertension associated with a 1 SD increment in serum antioxidant vitamin levels. Confounding of the association between BP and antioxidant vitamin levels was evaluated by adding possible confounders to the models. Two final models, age-, gender-, and race-adjusted model and multivariate-adjusted model (additional adjustment for education, alcohol consumption, and body mass index, dietary intake of sodium, potassium, saturated fat, and total energy) are presented. All statistical analyses were performed with the use of Stata software, which included functions for the analysis of complex survey data. 25 Results The general characteristics of study participants by hypertension status are presented in Table 1. On average, normotensives were 20 years younger than hypertensives. The percentages of male and non-hispanic whites were similar between the two groups, whereas normotensives had a lower proportion of non-hispanic blacks and a higher proportion of high school graduates and participants who consumed alcohol at least once per week. The prevalence of self-reported history of diabetes was significantly higher in hypertensives than in normotensives. As expected, normotensives had a lower mean body mass index and systolic and diastolic BP than their hypertensive counterparts. Normotensives reported a higher intake of dietary saturated fat and a lower intake of sodium and potassium compared with hypertensives. Mean
3 812 Hypertension December 2002 TABLE 2. Odds Ratio (95% CI) of Hypertension Associated With Serum Antioxidant Vitamins: Multivariate Logistic Regression Analysis* Age-, Gender-, and Race-Adjusted Multivariate-Adjusted Serum Vitamins, 1 SD OR (95% CI) P OR (95% CI) P Vitamin A, 16.2 g/dl 1.40 (1.31, 1.49) (1.34, 1.53) g/dl 0.76 (0.68, 0.85) (0.76, 0.94) g/dl 0.81 (0.73, 0.89) (0.82, 0.97) 0.01 Vitamin C, 0.47 mg/dl 0.91 (0.84, 0.99) (0.91, 1.07) 0.7 Vitamin E, 496 g/dl 1.18 (1.09, 1.27) (1.09, 1.27) SD indicates standard deviation. *n for age-, gender-, and race-adjusted analyses and n for multivariate-adjusted analyses. Adjusted for age, gender, race/ethnicity, education, alcohol consumption, body mass index, history of diabetes, dietary intake of sodium, potassium, saturated fat, and total energy. serum levels of antioxidant vitamins, including vitamins A, C, and E, and were significantly lower in normotensives compared with hypertensives. The self-reported vitamin supplement use during the past month was significantly correlated with serum levels of vitamin A (r 0.13), vitamin C (r 0.31), vitamin E (r 0.32), -carotene (r 0.15), and -carotene (r 0.18) among study participants. Dietary intake of vitamins from 24-hour recall was also significantly associated with serum levels of vitamin A (r 0.09), vitamin C (r 0.23), vitamin E (r 0.04), -carotene (r 0.19), and -carotene (r 0.16). of hypertension. After additional adjustment for education, alcohol consumption, body mass index, history of diabetes, dietary intake of sodium, potassium, saturated fat, and total energy, the relation between level of serum antioxidant vitamins and odds of hypertension remained significant, except for serum vitamin C. The odds ratio of hypertension associated with serum vitamin C was diminished and became nonsignificant in the multivariate-adjusted model. The relation between serum antioxidant vitamins and hypertension was consistent among subgroups defined by age, gender, and race/ethnicity (Table 3). Antioxidant Vitamins and Hypertension Table 2 depicts the odds ratios and 95% CIs for hypertension associated with 1 SD difference in level of serum vitamin A (16.2 g/dl), -carotene (4.8 g/dl), -carotene (20.4 g/dl), vitamin C (0.47 mg/dl), and vitamin E (496 g/dl). After adjustment for age, gender, and race/ethnicity, serum vitamins A and E were significantly associated with a higher odds of hypertension, whereas serum and vitamin C were significantly associated with a lower odds Antioxidant Vitamins and Blood Pressure Table 4 shows differences in systolic and diastolic BP associated with a 1 SD difference in levels of serum antioxidant vitamins. After adjustment for age, gender, and race/ ethnicity, vitamins A and E were positively and significantly associated with both systolic and diastolic BP, whereas and vitamin C were inversely and significantly associated with both systolic and diastolic BP. After additional adjustment for education, alcohol consump- TABLE 3. Odds Ratios (95% CI) for Hypertension Associated with Serum Level of Antioxidant Vitamins Among Age, Gender, and Race/Ethnicity Groups: Multivariate Logistic Regression Analysis Subgroups n Vitamin A, 16.2 g/dl 4.8 g/dl 20.4 g/dl Vitamin C, 0.47 mg/dl Vitamin E, 496 g/dl Age, y (1.29, 1.57) 0.79 (0.67, 0.92) 0.72 (0.61, 0.85) 0.93 (0.83, 1.03) 1.20 (1.05, 1.35) (1.25, 1.54) 0.89 (0.80, 0.99)* 0.99 (0.90, 1.08) 1.04 (0.96, 1.13) 1.09 (1.01, 1.18)* Gender Men (1.24, 1.53) 0.90 (0.77, 1.05) 0.92 (0.82, 1.03) 1.00 (0.88, 1.15) 1.14 (1.02, 1.29)* Women (1.30, 1.59) 0.79 (0.71, 0.87) 0.85 (0.77, 0.93) 0.94 (0.86, 1.02) 1.16 (1.05, 1.29) Race/ethnicity Non-Hispanic whites (1.32, 1.55) 0.82 (0.73, 0.92) 0.88 (0.79, 0.97) 1.00 (0.92, 1.10) 1.17 (1.07, 1.28) Non-Hispanic blacks (1.37, 1.59) 0.94 (0.84, 1.04) 0.98 (0.90, 1.07) 0.88 (0.77, 1.02) 1.33 (1.15, 1.54) Mexican-Americans (1.01, 1.32)* 0.82 (0.67, 1.01) 0.83 (0.71, 0.98)* 0.85 (0.72, 1.01) 1.12 (1.02, 1.23)* Values are adjusted for age, gender, race/ethnicity, education, alcohol consumption, history of diabetes, body mass index, dietary intake of sodium, potassium, saturated fat, and total energy, except for gender in men and women subgroups, and race in white, black, and Mexican-American subgroups. *P 0.05; P 0.01; and P
4 Chen et al Antioxidant Vitamins and Blood Pressure 813 TABLE 4. Effect of Serum Antioxidant Vitamins on SBP and DBP Levels: Multiple Linear Regression Analysis SBP, mm Hg DBP, mm Hg Serum Vitamins, 1 SD Effect (95% CI) P Effect (95% CI) P Vitamin A, 16.2 g/dl Age-, gender-, and race-adjusted 1.56 (1.15, 1.97) (1.13, 1.68) Multivariate-adjusted* 1.44 (1.01, 1.86) (1.03, 1.54) g/dl Age-, gender-, and race-adjusted 1.40 ( 1.83, 0.97) ( 0.58, 0.08) 0.01 Multivariate-adjusted* 0.86 ( 1.25, 0.47) ( 0.20, 0.22) g/dl Age-, gender-, and race-adjusted 1.47 ( 1.93, 1.00) ( 0.83, 0.35) Multivariate-adjusted* 0.92 ( 1.39, 0.45) ( 0.41, 0.01) 0.06 Vitamin C, 0.47 mg/dl Age-, gender-, and race-adjusted 0.69 ( 1.14, 0.24) ( 0.85, 0.32) Multivariate-adjusted* 0.10 ( 0.52, 0.32) ( 0.62, 0.13) Vitamin E, 496 g/dl Age-, gender-, and race-adjusted 0.70 (0.26, 1.14) (0.77, 1.26) Multivariate-adjusted* 0.66 (0.22, 1.11) (0.59, 1.08) Participants on antihypertensive medications were excluded. n for age-, gender-, and race-adjusted analyses and n for multivariate-adjusted analyses. *Adjusted for age, gender, education, alcohol consumption, body mass index, history of diabetes, dietary intake of sodium, potassium, saturated fat, and total energy. tion, body mass index, history of diabetes, dietary intake of sodium, potassium, saturated fat, and total energy, vitamins A and E remained positively and significantly associated with systolic and diastolic BP. In addition, -carotene and -carotene were inversely and significantly associated with systolic BP, whereas vitamin C was inversely and significantly associated with diastolic BP in multivariate-adjusted models. Table 5 shows multivariate-adjusted differences in systolic and diastolic BP associated with a1sddifference in level of serum antioxidant vitamins among specified subgroups by age, gender, race/ethnicity, and hypertension status. Serum vitamin A was positively and significantly associated with both systolic and diastolic BP in each subgroup, except in participants with hypertension. Serum -carotene was inversely and significantly related to systolic BP among most of the subgroups. Serum -carotene was inversely related to both systolic and diastolic BP in participants who were younger than 60 years, in women and in whites, and was related to systolic BP in men and in normotensives. Serum vitamin C was inversely associated with diastolic BP in participants who were younger than 60 years, in men and women, and in hypertensives and normotensives. In addition, serum vitamin C was inversely and significantly associated with both systolic and diastolic BP among blacks. Serum vitamin E was positively associated with both systolic and diastolic BP among most of the subgroups. Discussion Our study is one of the first to identify a significant and inverse relation between serum levels of -carotene and -carotene and risk of hypertension. It is also one of the first to recognize a significant and positive relation between serum levels of vitamin A and E and risk of hypertension in a human population. These relations were independent of age, gender, race, and other important risk factors for hypertension. In addition, our study identified a significant inverse relation between serum vitamin C and diastolic BP. These results suggest that antioxidant vitamins may play an important role in the underlying cause and prevention of hypertension. As such, they have important public health and clinical implications. Hypertension, a major risk factor for coronary heart disease, stroke, congestive heart failure, end-stage renal disease, and peripheral vascular disease, affects as many as 50 million adult Americans. 26 More than $34.4 billion is spent annually for medications, office visits, and laboratory tests related to treatment of hypertension in the US population. 27 Epidemiologic studies and clinical trials have demonstrated that nutritional factors play an important role in the underlying cause and prevention of hypertension. 28 The findings from our study provide new insights regarding the potential role of various antioxidant vitamins in modulating BP. Experimental studies in animal models suggest that oxidative stress may be important in the pathogenesis of hypertension or in the underlying cause of arterial damage related to hypertension. 29,30 However, there are scarce data in the relation between oxidative stress or antioxidants and BP in human populations. In cross-sectional studies, higher serum levels or dietary intake of vitamin C have been consistently and significantly related to lower systolic and diastolic BP among middle-aged or elderly populations However, there was insufficient attention to confounding effects by other dietary factors in most of these studies. 31 Several small
5 814 Hypertension December 2002 TABLE 5. Effect (95% CI) of Serum Antioxidant Vitamins on SBP and DBP Levels Among Age, Gender, and Race/Ethnicity Groups: Multiple Linear Regression Analysis Subgroups Vitamin A, 16.2 g/dl 4.8 g/dl 20.4 g/dl Vitamin C, 0.47 mg/dl Vitamin E, 496 g/dl Age, y (n 9092) SDP 1.49 (1.04, 1.94) 0.77 ( 1.17, 0.37) 1.36 ( 1.82, 0.90) 0.24 ( 0.68, 0.20) 0.60 (0.18, 1.02) DBP 1.48 (1.15, 1.80) 0.18 ( 0.43, 0.06) 0.42 ( 0.64, 0.20) 0.28 ( 0.54, 0.02)* 0.96 (0.62, 1.30) 60 (n 3010) SBP 0.81 (0.00, 1.62)* 0.60 ( 1.40, 0.20) 0.04 ( 0.63, 0.71) 0.00 ( 0.92, 0.93) 0.72 ( 0.09, 1.53) DBP 0.47 (0.06, 0.88)* 0.02 ( 0.48, 0.43) 0.11 ( 0.48, 0.25) 0.34 ( 0.74, 0.07) 0.18 ( 0.19, 0.54) Gender Men (n 5819) SBP 0.88 (0.30, 1.47) 0.82 ( 1.47, 0.18) 1.17 ( 1.83, 0.51) 0.36 ( 0.94, 0.21) 0.43 ( 0.11, 0.98) DBP 1.58 (1.17, 2.00) 0.12 ( 0.23, 0.46) 0.16 ( 0.53, 0.21) 0.45 ( 0.83, 0.07)* 1.20 (0.82, 1.59) Women (n 6283) SBP 1.77 (1.26, 2.28) 1.03 ( 1.42, 0.65) 1.01 ( 1.49, 0.54) 0.06 ( 0.55, 0.42) 0.57 ( 0.17, 1.31) DBP 0.98 (0.65, 1.31) 0.10 ( 0.30, 0.11) 0.29 ( 0.52, 0.07) 0.36 ( 0.63, 0.10) 0.37 ( 0.01, 0.74) Race Whites (n 6273) SBP 1.72 (1.27, 2.16) 1.25 ( 1.64, 0.86) 1.15 ( 1.70, 0.61) 0.11 ( 0.29, 0.52) 0.86 (0.44, 1.28) DBP 1.23 (0.93, 1.52) 0.04 ( 0.21, 0.29) 0.22 ( 0.44, 0.00)* 0.20 ( 0.43, 0.03) 0.89 (0.64, Blacks (n 4050) SBP 1.72 (0.87, 2.56) 0.12 ( 0.51, 0.28) 0.06 ( 0.64, 0.75) 1.38 ( 2.28, 0.48) 1.70 (0.77, 2.62) DBP 1.01 (0.34, 1.67) 0.11 ( 0.37, 0.14) 0.22 ( 0.62, 0.18) 1.01 ( 1.45, 0.57) 0.67 (0.06, 1.28)* Mexican-Americans (n 4195) SBP 1.32 (0.64, 2.00) 0.83 ( 1.70, 0.04) 0.36 ( 1.22, 0.50) 0.42 ( 1.05, 0.21) 0.43 ( 0.24, 1.09) DBP 1.01 (0.55, 1.47) 0.04 ( 0.54, 0.47) 0.32 ( 0.69, 0.04) 0.31 ( 0.74, 0.12) 1.23 (0.70, 1.75) Hypertensives (n 2119) SBP 0.33 ( 1.10, 0.44) 0.28 ( 1.02, 0.47) 0.11 ( 0.58, 0.80) 0.42 ( 1.07, 0.23) 0.39 ( 1.15, 0.36) DBP 0.22 ( 0.28, 0.73) 0.35 ( 0.24, 0.94) 0.08 ( 0.57, 0.72) 0.67 ( 1.14, 0.20) 0.13 ( 0.40, 0.66) Normotensives (n 9983) SBP 1.19 (0.83, 1.56) 0.48 ( 0.77, 0.18) 0.65 ( 1.02, 0.28) 0.05 ( 0.42, 0.32) 0.55 (0.25, 0.85) DBP 1.24 (0.95, 1.53) 0.07 ( 0.14, 0.28) 0.06 ( 0.24, 0.13) 0.23 ( 0.46, 0.01)* 0.80 (0.53, 1.06) Adjusted for age, gender, race/ethnicity, education, alcohol consumption, body mass index, history of diabetes, dietary intake of sodium, potassium, saturated fat, and total energy, except for gender in men and women subgroups, and race in white, black, and Mexican-American subgroups. Participants on antihypertensive medications were excluded. *P 0.05; P 0.01; P clinical trials that have tested the effect of vitamin C supplementation on BP have yielded inconsistent findings For example, Fotherby and colleagues 17 found that BP was not reduced after supplementation with 500 mg vitamin C per day for 3 months in a double-blind, randomized, placebo-controlled crossover study. However, daytime levels of ambulatory systolic BP was slightly but significantly reduced, by 2.0 mm Hg (95% CI, 0 to 3.9 mm Hg), in the vitamin C supplementation phase compared with the placebo control phase. Our study identified an inverse association between serum vitamin C level and risk of hypertension and BP in age, gender, and race-adjusted analyses. After further adjustment for other risk factors including dietary nutrients, serum vitamin C level was only significantly related to diastolic BP. Furthermore, our study indicated that serum vitamin C level was significantly related to both systolic and diastolic BP in blacks who had a lower mean level of serum vitamin C. These findings might imply that low intake of dietary vitamin C related to increased risk of hypertension. To the best our knowledge, the present study is the first to have examined the relation between serum carotene levels and BP in a human population. Our study identified an inverse relation between serum levels of -carotene and -carotene and risk of hypertension and systolic BP. In a randomized crossover trial conducted in 21 hypertensive patients, a combination of antioxidants consisting of 200 mg of zinc sulfate, 500 mg of vitamin C, 600 mg of -tocopherol, and 30 mg of -carotene per day significantly lowered systolic BP. 32 However, in a larger randomized controlled
6 Chen et al Antioxidant Vitamins and Blood Pressure 815 trial conducted in 297 participants, combined antioxidant vitamin capsules providing 400 IU vitamin E, 500 mg vitamin C, and 6 mg -carotene per day did not reduce BP during a 2- to 4-month period of intervention. 33 Future studies are required to confirm our findings and to examine the independent effect of carotene on BP. Our study is one of the first to report a strong, independent, and positive association between higher serum vitamin A level and increased risk of hypertension and BP in a large population sample. The association was consistent across age, gender, and race groups. This finding is in conflict with the results from two previous reports. In the First National Health and Nutrition Examination Survey population, a significant decrease in dietary intake of vitamin A was identified in hypertensives compared with normotensives. 34 In addition, a significant decrease in plasma vitamin A level was reported in 105 hypertensive patients compared with 100 normotensive controls. 29 In the NHANES III study population, we have also identified a positive and significant association between serum vitamin A level and risk of chronic kidney disease. 35 Serum level of vitamin E was significantly and positively related with both systolic and diastolic BP in our study. Experimental studies have shown that vitamin E decreases BP in animal models. 36,37 However, data from human populations are more inconsistent. For example, epidemiologic studies have reported that serum level of vitamin E is reduced 29 or is no different 38 in hypertensive patients compared with normotensive control subjects. Palumbo et al 20 found that vitamin E supplementation had no effect on BP in treated hypertensive patients in a randomized, controlled, open trial. Our findings of a positive and independent relation between serum vitamin E and BP call for further investigation in this important area. Several large clinical trials, which examined the effect of -carotene or vitamin E supplements on risk of cardiovascular disease, have reported negative results. 7 9 For example, Yusuf and colleagues 9 summarized 4 major clinical trials of vitamin E supplementation with a total of participants in the treatment group and participants in the placebo control group. The relative risk of cardiovascular disease associated with vitamin E supplementation was 0.97, with a 95% CI from 0.92 to 1.02 (P 0.27). The recently completed Heart Protection Study indicates that antioxidant vitamin supplementation (650 mg vitamin E, 250 mg vitamin C, and 20 mg -carotene) does not reduce risk of cardiovascular disease among participants during 5 years of followup. 39,40 Our study raises new concerns on vitamin A and E supplement use in the general population. Our findings are noteworthy because they are based on experience in a large, representative sample of the US general population, where careful measurement of BP and serum vitamin levels allowed for more reliable assessment of the association, and it was possible to adjust for consumption of dietary nutrient and other important covariables. However, the cross-sectional study design used in NHANES III hinders making inferences regarding causality between antioxidant vitamins and BP. For instance, we cannot establish the temporal relation between serum levels of antioxidant vitamins and BP. In addition, oversampling some subgroups and imperfect response rates may affect the representation of the sample. Furthermore, serum level of antioxidant vitamins may be a marker for other confounding factors. If the relation between antioxidant vitamins and risk of hypertension is confirmed in large cohort studies, then randomized, controlled trials with sufficient sample size and intervention duration will be needed to test for causality. Perspectives Our study findings indicate that vitamin C, and -carotene are inversely associated with BP, whereas vitamins A and E are positively associated with BP. These relations are stronger in normotensive and younger participants. These findings suggest that antioxidant vitamins may play an important role in the underlying cause and prevention of hypertension. With increased recognition of oxidative stress in the pathogenesis of hypertension and wide use of antioxidant vitamins in the general population, further investigations are warranted in this important area. Acknowledgments This study was supported in part by grant R01HL60300 from the National Heart, Lung, and Blood Institute of the National Institutes of Health. References 1. Diaz MN, Frei B, Vita JA, Keaney JF Jr. Antioxidants and atherosclerotic heart disease. N Engl J Med. 1997;337: Tribble DL. AHA Science Advisory. Antioxidant consumption and risk of coronary heart disease: emphasis on vitamin C, vitamin E, and betacarotene: a statement for healthcare professionals from the American Heart Association. Circulation. 1999;99: Spencer AP. Carson DS. Crouch MA. Vitamin E and coronary artery disease. Arch Intern Med. 1999;159: Stampfer MJ, Hennekens CH, Manson JE, Colditz GA, Rosner B, Willett WC. Vitamin E consumption and the risk of coronary disease in women. N Engl J Med. 1993;328: Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA, Willett WC. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med. 1993;328: Kushi LH, Folsom AR, Prineas RJ, Mink PJ, Wu Y, Bostick RM. Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women. N Engl J Med. 1996;334: Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med. 1994;330: Hennekens CH, Buring JE, Manson JE, Stampfer M, Rosner B, Cook NR, Belanger C, LaMotte F, Gaziano JM, Ridker PM, Willett W, Peto R. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med. 1996;334: Yusuf S, Dagenais G, Pogue J, Bosch J, Sleight P. Vitamin E supplementation and cardiovascular events in high-risk patients. N Engl J Med. 2000;342: Yoshioka M, Matsushita T, Chuman Y. Inverse association of serum ascorbic acid level and blood pressure or rate of hypertension in male adults aged years. Int J Vitam Nutr Res. 1984;54: Sakai N, Yokoyama T, Date C, Yoshiike N, Matsumura Y. Inverse relationship between serum vitamin C and blood pressure in a Japanese community. J Nutr Sci Vitaminol. 1998;44: Jacquesm PF. A cross-sectional study of vitamin C intake and blood pressure in the elderly. Int J Vitam Nutr Res. 1992;62: Moran JP, Cohen L, Greene JM, Xu G, Feldman EB, Hames CG, Feldman DS. Plasma ascorbic acid concentrations relate inversely to blood pressure in human subjects. Am J Clin Nutr. 1993;57: Bates CJ, Walmsley CM, Prentice A, Finch S. Does vitamin C reduce blood pressure? Results of a large study of people aged 65 or older. J Hypertens. 1998;16:
7 816 Hypertension December Ness AR, Khaw KT, Bingham S, Day NE. Vitamin status and blood pressure. J Hypertens. 1996;14: Duffy SJ, Gokce N, Holbrook M, Huang A, Frei B, Keaney JF Jr, Vita JA. Treatment of hypertension with ascorbic acid. Lancet. 1999;354: Fotherby MD, Williams JC, Forster LA, Craner P, Ferns GA. Effect of vitamin C on ambulatory blood pressure and plasma lipids in older persons. J Hypertens. 2000;18: Block G, Mangels AR, Norkus EP, Patterson BH, Levander OA, Taylor PR. Ascorbic acid status and subsequent diastolic and systolic blood pressure. Hypertension. 2001;37: Ghosh SK, Ekpo EB, Shah IU, Girling AJ, Jenkins C, Sinclair AJ. A double-blind, placebo-controlled parallel trial of vitamin C treatment in elderly patients with hypertension. Gerontology. 1994;40: Palumbo G, Avanzini F, Alli C, Roncaglioni MC, Ronchi E, Cristofari M, Capra A, Rossi S, Nosotti L, Costantini C, Cavalera C. Effects of vitamin E on clinic and ambulatory blood pressure in treated hypertensive patients. Am J Hypertens. 2000;13: Woo J, Ho SC, Donnan S, Swaminathan R. Nutritional correlates of blood pressure in elderly Chinese. J Hum Hypertens. 1988;1: McCarron DA, Morris CD, Henry HJ, Stanton JL. Blood pressure and nutrient intake in the United States. Science. 1984;224: National Center for Health Statistics. Plan and operation of the Third National Health and Nutrition Examination Survey Vital Health Stat ;32: Gunter EW, Lewis BG, Koncikowski SM. Laboratory Procedures Used for the Third Health and Nutrition Examination Survey (NHANES III), Atlanta, Ga: US Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, Center for Environmental Health. Hyattsville, Md: National Center for Health Statistics; StataCorp. Stata Statistical Software: Release 5.0 College Station, Tex: Stata Corporation; Wolz M, Cutler J, Roccella EJ, Rohde F, Thom T, Burt V. Statement from the National High Blood Pressure Education Program: Prevalence of hypertension. Am J Hypertens. 2000;13: American Heart Association Heart and Stroke Statistical Update. Dallas, Tex: American Heart Association; Appel LJ, Moore TJ, Obarzanek E, Vollmer WM, Svetkey LP, Sacks FM, Bray GA, Vogt TM, Cutler JA, Windhauser MM, Lin PH, Karanja N. A clinical trial of the effects of dietary patterns on blood pressure. N Engl J Med. 1997;336: Russo C, Olivieri O, Girelli D, Faccini G, Zenari ML, Lombardi S, Corrocher R. Antioxidant status and lipid peroxidation in patients with essential hypertension. J Hypertens. 1998;16: Parik T, Allikmets K, Teesalu R, Zilmer M. Evidence for oxidative stress in essential hypertension: perspective for antioxidant therapy. J Cardiovasc Risk. 1996;3: Ness AR, Chee D, Elliott P. Vitamin C and blood pressure: an overview. J Hum Hypertens. 1997;11: Galley HF, Thornton J, Howdle PD, Walker BE, Webster NR. Combination oral antioxidant supplementation reduces blood pressure. Clin Sci. 1997;92: Miller ER, Appel LJ, Levander OA, Levine DM. The effect of antioxidant vitamin supplementation on traditional cardiovascular risk factors. J Cardiovasc Risk. 1997;4: McCarron DA, Morris CD, Henry HJ, Stanton JL. Blood pressure and nutrient intake in the United States. Science. 1984;224: Chen J, He J, Ogden LJ, Batuman V, Whelton PK. Relationship of serum antioxidant vitamins to hypercreatinemia in US general population. Am J Kidney Dis. 2002;39: Koba K, Abe K, Ikeda I, Sugano M. Effects of alpha-tocopherol and tocotrienols on blood pressure and linoleic acid metabolism in the spontaneously hypertensive rat. Biosci Biotechnol Biochem. 1992;56: Pezeshk A, Derick Dalhouse A. Vitamin E, membrane fluidity, and blood pressure in hypertensive and normotensive rats. Life Sci. 2000;67: Tse WY, Maxwell SR, Thomason H, Blann A, Thorpe GH, Waite M, Holder R. Antioxidant status in controlled and uncontrolled hypertension and its relationship to endothelial damage. J Hum Hypertens. 1994;8: Collins R, Peto R, Armitage J. The MRC/BHF Heart Protection Study: preliminary results. Int J Clin Pract. 2002;56: MRC/BHF Heart Protection Study. Preliminary Results Slideshow. Available at: Accessed October 3, 2002.
Hypertension is an important public health challenge in
Scientific Contributions Long-Term Absolute Benefit of Lowering Blood Pressure in Hypertensive Patients According to the JNC VI Risk Stratification Lorraine G. Ogden, Jiang He, Eva Lydick, Paul K. Whelton
More informationDietary Fatty Acids and the Risk of Hypertension in Middle-Aged and Older Women
07/14/2010 Dietary Fatty Acids and the Risk of Hypertension in Middle-Aged and Older Women First Author: Wang Short Title: Dietary Fatty Acids and Hypertension Risk in Women Lu Wang, MD, PhD, 1 JoAnn E.
More informationHypertension awareness, treatment, and control
O r i g i n a l P a p e r Prevalence of Self-Reported High Blood Pressure Awareness, Advice Received From Health Professionals, and Actions Taken to Reduce High Blood Pressure Among US Adults Healthstyles
More informationInternational Journal of Basic, Applied and Innovative Research IJBAIR, 2012, 1(1):
ASN- PH-020919 International Journal of Basic, Applied and Innovative Research IJBAIR, 2012, 1(1):26-31 www.antrescentpub.com RESEARCH PAPER FRUITS INTAKE AND CARDIOVASCULAR FUNCTION IN NORMOTENSIVE YOUNG
More informationThe presence of cardiovascular disease risk factors, clinical
The Impact of JNC-VI Guidelines on Treatment Recommendations in the US Population Paul Muntner, Jiang He, Edward J. Roccella, Paul K. Whelton Abstract Using epidemiological and clinical trial evidence,
More informationIn a recent meta-analysis of randomized clinical trials, Miller
Brief Communication: The Prevalence of High Intake of Vitamin E from the Use of Supplements among U.S. Adults Earl S. Ford, MD, MPH; Umed A. Ajani, MBBS, MPH; and Ali H. Mokdad, PhD Article Background:
More informationLydia A Bazzano, Jiang He, Lorraine G Ogden, Catherine M Loria, Suma Vupputuri, Leann Myers, and Paul K Whelton
Fruit and vegetable intake and risk of cardiovascular disease in US adults: the first National Health and Nutrition Examination Survey Epidemiologic Follow-up Study 1 3 Lydia A Bazzano, Jiang He, Lorraine
More informationHealth Benefits of Lowering Sodium Intake in the US
Health Benefits of Lowering Sodium Intake in the US Lawrence J Appel, MD, MPH Professor of Medicine, Epidemiology and International Health (Human Nutrition) Director, Welch Center for Prevention, Epidemiology
More informationPOTASSIUM. The Facts. compiled by the Nestlé Research Center
POTASSIUM The Facts compiled by the Nestlé Research Center A public health concern? Studies have shown that a diet high in sodium or low in potassium is linked with a higher risk for elevated blood pressure
More informationORIGINAL INVESTIGATION. Legume Consumption and Risk of Coronary Heart Disease in US Men and Women
ORIGINAL INVESTIGATION Legume Consumption and Risk of Coronary Heart Disease in US Men and Women NHANES I Epidemiologic Follow-up Study Lydia A. Bazzano, PhD; Jiang He, MD, PhD; Lorraine G. Ogden, MS;
More informationHypertension is an important worldwide public health
Long-Term Effects of Weight Loss and Dietary Sodium Reduction on Incidence of Hypertension Jiang He, Paul K. Whelton, Lawrence J. Appel, Jeanne Charleston, Michael J. Klag Abstract To examine the long-term
More informationA Dietary Approach to Prevent Hypertension: A Review of the Dietary Approaches to Stop Hypertension (DASH) Study
Clin. Cardiol. 22, (Suppl. 111), 111611110 (1999) A Dietary Approach to Prevent Hypertension: A Review of the Dietary Approaches to Stop Hypertension (DASH) Study FRANKM. SACKS, M.D., LAWRENCE J. &pa,
More informationHypertension, which affects approximately 50 million
AJH 2001; 14:206S 212S Are Low Intakes of Calcium and Potassium Important Causes of Cardiovascular Disease? David A. McCarron and Molly E. Reusser Inadequate levels of calcium and potassium intake have
More informationORIGINAL INVESTIGATION. C-Reactive Protein Concentration and Incident Hypertension in Young Adults
ORIGINAL INVESTIGATION C-Reactive Protein Concentration and Incident Hypertension in Young Adults The CARDIA Study Susan G. Lakoski, MD, MS; David M. Herrington, MD, MHS; David M. Siscovick, MD, MPH; Stephen
More informationA n aly tical m e t h o d s
a A n aly tical m e t h o d s If I didn t go to the screening at Farmers Market I would not have known about my kidney problems. I am grateful to the whole staff. They were very professional. Thank you.
More informationThe oxidative modification hypothesis of coronary heart
Plasma Carotenoids and Tocopherols and Risk of Myocardial Infarction in a Low-Risk Population of US Male Physicians A. Elisabeth Hak, MD, PhD; Meir J. Stampfer, MD, DrPH; Hannia Campos, PhD; Howard D.
More informationT. Suithichaiyakul Cardiomed Chula
T. Suithichaiyakul Cardiomed Chula The cardiovascular (CV) continuum: role of risk factors Endothelial Dysfunction Atherosclerosis and left ventricular hypertrophy Myocardial infarction & stroke Endothelial
More informationUsing the New Hypertension Guidelines
Using the New Hypertension Guidelines Kamal Henderson, MD Department of Cardiology, Preventive Medicine, University of North Carolina School of Medicine Kotchen TA. Historical trends and milestones in
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Schneider ALC, Wang D, Ling G, Gottesman RF, Selvin E. Prevalence
More informationTHERE is growing evidence that the oxidative modification
1156 THE NEW ENGLAND JOURNAL OF MEDICINE May 2, 1996 DIETARY ANTIOXIDANT VITAMINS AND DEATH FROM CORONARY HEART DISEASE IN POSTMENOPAUSAL WOMEN LAWRENCE H. KUSHI, SC.D., AARON R. FOLSOM, M.D., RONALD J.
More informationORIGINAL INVESTIGATION. Glycemic Index and Serum High-Density Lipoprotein Cholesterol Concentration Among US Adults
Glycemic Index and Serum High-Density Lipoprotein Cholesterol Concentration Among US Adults Earl S. Ford, MD; Simin Liu, MD ORIGINAL INVESTIGATION Background: Dietary glycemic index, an indicator of the
More informationWhy Do We Treat Obesity? Epidemiology
Why Do We Treat Obesity? Epidemiology Epidemiology of Obesity U.S. Epidemic 2 More than Two Thirds of US Adults Are Overweight or Obese 87.5 NHANES Data US Adults Age 2 Years (Crude Estimate) Population
More informationPage down (pdf converstion error)
1 of 6 2/10/2005 7:57 PM Weekly August6, 1999 / 48(30);649-656 2 of 6 2/10/2005 7:57 PM Achievements in Public Health, 1900-1999: Decline in Deaths from Heart Disease and Stroke -- United States, 1900-1999
More informationMagnesium intake and serum C-reactive protein levels in children
Magnesium Research 2007; 20 (1): 32-6 ORIGINAL ARTICLE Magnesium intake and serum C-reactive protein levels in children Dana E. King, Arch G. Mainous III, Mark E. Geesey, Tina Ellis Department of Family
More informationAlthough the association between blood pressure and
Two-Year Changes in Blood Pressure and Subsequent Risk of Cardiovascular Disease in Men Howard D. Sesso, ScD, MPH; Meir J. Stampfer, MD, DrPH; Bernard Rosner, PhD; J. Michael Gaziano, MD, MPH; Charles
More informationARIC Manuscript Proposal # PC Reviewed: 2/10/09 Status: A Priority: 2 SC Reviewed: Status: Priority:
ARIC Manuscript Proposal # 1475 PC Reviewed: 2/10/09 Status: A Priority: 2 SC Reviewed: Status: Priority: 1.a. Full Title: Hypertension, left ventricular hypertrophy, and risk of incident hospitalized
More informationw High Blood Pressure Guidelines Create New At-Risk Classification
Journal of Cardiovascular Nursing Vol. 19, No. 6, pp 357-371 2004 LippincoltWilliams SWilkins, Inc. w High Blood Pressure Guidelines Create New At-Risk Classification Changes in Blood Pressure Classification
More informationThe New England Journal of Medicine
The New England Journal of Medicine Copyright 2001 by the Massachusetts Medical Society VOLUME 345 A UGUST 16, 2001 NUMBER 7 CHARACTERISTICS OF PATIENTS WITH UNCONTROLLED IN THE UNITED STATES DAVID J.
More informationDownloaded from journal.bums.ac.ir at 23:16 IRST on Saturday February 16th 2019
( ) - - - - :.. - : HDL-C.. ( )... P / t () : (P
More informationA PROSPECTIVE STUDY OF CIGARETTE SMOKING AND RISK OF INCIDENT HYPERTENSION IN WOMEN
A PROSPECTIVE STUDY OF CIGARETTE SMOKING AND RISK OF INCIDENT HYPERTENSION IN WOMEN Thomas S. Bowman, MD, MPH, J. Michael Gaziano, MD, MPH, Julie E. Buring ScD and Howard D. Sesso ScD, MPH From the Veterans
More informationAssociation between serum 25-hydroxyvitamin D and depressive symptoms in Japanese: analysis by survey season
University of Massachusetts Amherst From the SelectedWorks of Kalpana Poudel-Tandukar Summer August 19, 2009 Association between serum 25-hydroxyvitamin D and depressive symptoms in Japanese: analysis
More informationVitamin E and heart disease: a case study 1,2
Vitamin E and heart disease: a case study 1,2 Lawrence H Kushi ABSTRACT The role of nutritional epidemiology studies in the development of nutritional recommendations has been controversial, in part because
More informationMeasures of Obesity and Cardiovascular Risk Among Men and Women
Journal of the American College of Cardiology Vol. 52, No. 8, 2008 2008 by the American College of Cardiology Foundation ISSN 0735-1097/08/$34.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2008.03.066
More informationORIGINAL INVESTIGATION. Effects of Prehypertension on Admissions and Deaths
ORIGINAL INVESTIGATION Effects of Prehypertension on Admissions and Deaths A Simulation Louise B. Russell, PhD; Elmira Valiyeva, PhD; Jeffrey L. Carson, MD Background: The Joint National Committee on Prevention,
More informationORIGINAL INVESTIGATION. Alcohol Consumption and Mortality in Men With Preexisting Cerebrovascular Disease
ORIGINAL INVESTIGATION Alcohol Consumption and Mortality in Men With Preexisting Cerebrovascular Disease Vicki A. Jackson, MD; Howard D. Sesso, ScD; Julie E. Buring, ScD; J. Michael Gaziano, MD Background:
More informationWe have recently published blood pressure (BP) percentiles
Blood Pressure Differences by Ethnic Group Among United States Children and Adolescents Bernard Rosner, Nancy Cook, Ron Portman, Steve Daniels, Bonita Falkner Abstract Large differences in blood pressure
More informationOptimal blood pressure targets in chronic kidney disease
Optimal blood pressure targets in chronic kidney disease Pr. Michel Burnier Service of Nephrology and Hypertension University Hospital Lausanne Switzerland Evidence-Based Guideline for the Management
More informationEgg consumption and CHD and stroke mortality: a prospective study of US adults
Public Health Nutrition: 14(2), 261 270 doi:10.1017/s1368980010001874 Egg consumption and CHD and stroke mortality: a prospective study of US adults Carolyn G Scrafford 1,2, *, Nga L Tran 1,3, Leila M
More informationA Prospective Study of Cigarette Smoking and Risk of Incident Hypertension in Women
Journal of the American College of Cardiology Vol. 50, No. 21, 2007 2007 by the American College of Cardiology Foundation ISSN 0735-1097/07/$32.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2007.08.017
More informationThe effect of a change in ambient temperature on blood pressure in normotensives
(2001) 15, 113 117 2001 Nature Publishing Group All rights reserved 0950-9240/01 $15.00 www.nature.com/jhh ORIGINAL ARTICLE The effect of a change in ambient temperature on blood pressure in normotensives
More informationStatistical Fact Sheet Populations
Statistical Fact Sheet Populations At-a-Glance Summary Tables Men and Cardiovascular Diseases Mexican- American Males Diseases and Risk Factors Total Population Total Males White Males Black Males Total
More informationDiet Quality and History of Gestational Diabetes
Diet Quality and History of Gestational Diabetes PUBLIC HEALTH RESEARCH, PRACTICE, AND POLICY Volume 12, E25 FEBRUARY 2015 ORIGINAL RESEARCH Diet Quality and History of Gestational Diabetes Mellitus Among
More informationBlood pressure and risk of developing type 2 diabetes mellitus: The Women s Health Study
European Heart Journal (2007) 28, 2937 2943 doi:10.1093/eurheartj/ehm400 Clinical research Hypertension Blood pressure and risk of developing type 2 diabetes mellitus: The Women s Health Study David Conen
More informationHIGH BLOOD PRESSURE IS AN EStablished
ORIGINAL CONTRIBUTION Trends in Blood Pressure Among Children and Adolescents Paul Muntner, PhD Jiang He, MD, PhD Jeffrey A. Cutler, MD Rachel P. Wildman, PhD Paul K. Whelton, MD, MSc HIGH BLOOD PRESSURE
More informationEpidemiological studies indicate that a parental or family
Maternal and Paternal History of Myocardial Infarction and Risk of Cardiovascular Disease in Men and Women Howard D. Sesso, ScD, MPH; I-Min Lee, MBBS, ScD; J. Michael Gaziano, MD, MPH; Kathryn M. Rexrode,
More informationNIH Public Access Author Manuscript JAMA Intern Med. Author manuscript; available in PMC 2015 August 01.
NIH Public Access Author Manuscript Published in final edited form as: JAMA Intern Med. 2014 August ; 174(8): 1397 1400. doi:10.1001/jamainternmed.2014.2492. Prevalence and Characteristics of Systolic
More informationMisperceptions still exist that cardiovascular disease is not a real problem for women.
Management of Cardiovascular Risk Factors in the Cynthia A., MD University of California, San Diego ARHP 9/19/08 Disclosures Research support Wyeth, Lilly, Organon, Novo Nordisk, Pfizer Consultant fees
More informationORIGINAL INVESTIGATION. Dietary Sodium Intake and Incidence of Congestive Heart Failure in Overweight US Men and Women
ORIGINAL INVESTIGATION Dietary Sodium Intake and Incidence of Congestive Heart Failure in Overweight US Men and Women First National Health and Nutrition Examination Survey Epidemiologic Follow-up Study
More informationA Needs Assessment of Hypertension in Georgia
A Needs Assessment of Hypertension in Georgia Faye Lopez Mercer University School of Medicine Marylen Rimando Mercer University School of Medicine Harshali Khapekar Mercer University School of Medicine
More informationAspirin prevents stroke but not MI in women; Vitamin E has no effect on CV disease or cancer
MEDICAL GRAND ROUNDS CME CREDIT JULIE E. BURING, ScD* Professor of Medicine, Harvard Medical School; Division of Preventive Medicine, Brigham and Women s Hospital, Boston; principal investigator, Women
More informationA Study on Prevalence of Hypertension among Chronic Kidney Disease Patients admitted in the Nephrology Department of CAIMS, Karimnagar
Original Article A Study on Prevalence of Hypertension among Chronic Kidney Disease Patients admitted in the Nephrology Department of CAIMS, Karimnagar Murari Rajendra Prasad 1, Gopal Rao Jogdand 2, Mahesh
More informationNew Hypertension Guideline Recommendations for Adults July 7, :45-9:30am
Advances in Cardiovascular Disease 30 th Annual Convention and Reunion UERM-CMAA, Inc. Annual Convention and Scientific Meeting July 5-8, 2018 New Hypertension Guideline Recommendations for Adults July
More informationFolate, vitamin B 6, and vitamin B 12 are cofactors in
Research Letters Dietary Folate and Vitamin B 6 and B 12 Intake in Relation to Mortality From Cardiovascular Diseases Japan Collaborative Cohort Study Renzhe Cui, MD; Hiroyasu Iso, MD; Chigusa Date, MD;
More informationNutrition-based approaches are recommended
AJH 2000;13:949 955 ORIGINAL CONTRIBUTIONS The Effect of Dietary Patterns on Blood Pressure Control in Hypertensive Patients: Results From the Dietary Approaches to Stop Hypertension (DASH) Trial Paul
More informationTrends in Prevalence, Awareness, Management, and Control of Hypertension Among United States Adults, 1999 to 2010
Journal of the American College of Cardiology Vol. 60, No. 7, 2012 2012 by the American College of Cardiology Foundation ISSN 0735-1097/$36.00 Published by Elsevier Inc. http://dx.doi.org/10.1016/j.jacc.2012.04.026
More informationPrevalence, awareness, treatment and control of hypertension in North America, North Africa and Asia
(2004) 18, 545 551 & 2004 Nature Publishing Group All rights reserved 0950-9240/04 $30.00 www.nature.com/jhh REVIEW ARTICLE Prevalence, awareness, treatment and control of hypertension in North America,
More informationHYPERTENSION: ARE WE GOING TOO LOW?
HYPERTENSION: ARE WE GOING TOO LOW? George L. Bakris, M.D.,F.A.S.N.,F.A.S.H., F.A.H.A. Professor of Medicine Director, ASH Comprehensive Hypertension Center University of Chicago Medicine Chicago, IL USA
More informationConsumption of fruits and vegetables has been shown to
Intake of Flavonoids, Carotenoids, Vitamins C and E, and Risk of Stroke in Male Smokers Tero Hirvonen, MSc; Jarmo Virtamo, MD; Pasi Korhonen, MSc; Demetrius Albanes, MD; Pirjo Pietinen, DSc Background
More informationBlood Pressure Targets in Diabetes
Stockholm, 29 th August 2010 ESC Meeting Blood Pressure Targets in Diabetes Peter M Nilsson, MD, PhD Department of Clinical Sciences University Hospital, Malmö Sweden Studies on BP in DM2 ADVANCE RCT (Lancet
More informationResearch Article Prevalence and Trends of Adult Obesity in the US,
ISRN Obesity, Article ID 185132, 6 pages http://dx.doi.org/.1155/14/185132 Research Article Prevalence and Trends of Adult Obesity in the US, 1999 12 Ruopeng An CollegeofAppliedHealthSciences,UniversityofIllinoisatUrbana-Champaign,GeorgeHuffHallRoom13,16South4thStreet,
More informationNutritional Risk Factors for Peripheral Vascular Disease: Does Diet Play a Role?
Nutritional Risk Factors for Peripheral Vascular Disease: Does Diet Play a Role? John S. Lane MD, Cheryl P. Magno MPH, Karen T. Lane MD, Tyler Chan BS, Sheldon Greenfield MD University of California, Irvine
More information2003 World Health Organization (WHO) / International Society of Hypertension (ISH) Statement on Management of Hypertension.
2003 World Health Organization (WHO) / International Society of Hypertension (ISH) Statement on Management of Hypertension Writing Group: Background Hypertension worldwide causes 7.1 million premature
More informationLEAD EXPOSURE IS AN IMPORTANT
ORIGINAL CONTRIBUTION Relationship of Ascorbic Acid to Blood Lead Levels Joel A. Simon, MD, MPH Esther S. Hudes, PhD, MPH See also pp 2294 and 234 and Patient Page. Context Some animal studies suggest
More informationThe hypothesis that antioxidant vitamins may exert
Scientific Contributions Lack of Long-Term Effect of Vitamin C Supplementation on Blood Pressure Mi Kyung Kim, Satoshi Sasaki, Shizuka Sasazuki, Shunji Okubo, Masato Hayashi, Shoichiro Tsugane Abstract
More informationKathryn M. Rexrode, MD, MPH. Assistant Professor. Division of Preventive Medicine Brigham and Women s s Hospital Harvard Medical School
Update: Hormones and Cardiovascular Disease in Women Kathryn M. Rexrode, MD, MPH Assistant Professor Division of Preventive Medicine Brigham and Women s s Hospital Harvard Medical School Overview Review
More informationBody Mass Index and Blood Pressure in Adult Type 2 Diabetic Patients in Taiwan
Circ J 2007; 71: 1749 1754 Body Mass Index and Blood Pressure in Adult Type 2 Diabetic Patients in Taiwan Chin-Hsiao Tseng, MD, PhD*, **,,, Background The correlation between body mass index (BMI)/obesity
More informationHypertension in the South-East Asia Region: an overview
Hypertension in the South-East Asia Region: an overview Anand Krishnan i, Renu Garg ii and Athula Kahandaliyanage iii Abstract Raised blood pressure or hypertension is the single most important risk factor
More informationSlide notes: References:
1 2 3 Cut-off values for the definition of hypertension are systolic blood pressure (SBP) 135 and/or diastolic blood pressure (DBP) 85 mmhg for home blood pressure monitoring (HBPM) and daytime ambulatory
More informationORIGINAL INVESTIGATION. Risk Factors for Congestive Heart Failure in US Men and Women
ORIGINAL INVESTIGATION Risk Factors for Congestive Heart Failure in US Men and Women NHANES I Epidemiologic Follow-up Study Jiang He, MD, PhD; Lorraine G. Ogden, MS; Lydia A. Bazzano, PhD; Suma Vupputuri,
More informationSUPPLEMENTARY DATA. Supplementary Figure S1. Cohort definition flow chart.
Supplementary Figure S1. Cohort definition flow chart. Supplementary Table S1. Baseline characteristics of study population grouped according to having developed incident CKD during the follow-up or not
More informationBiostats Final Project Fall 2002 Dr. Chang Claire Pothier, Michael O'Connor, Carrie Longano, Jodi Zimmerman - CSU
Biostats Final Project Fall 2002 Dr. Chang Claire Pothier, Michael O'Connor, Carrie Longano, Jodi Zimmerman - CSU Prevalence and Probability of Diabetes in Patients Referred for Stress Testing in Northeast
More informationHow have the national estimates of dietary sugar consumption changed over time among specific age groups from 2007 to 2012?
How have the national estimates of dietary sugar consumption changed over time among specific age groups from 2007 to 2012? DATA FROM THE NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEY (NHANES) CYCLES
More informationWhat s In the New Hypertension Guidelines?
American College of Physicians Ohio/Air Force Chapters 2018 Scientific Meeting Columbus, OH October 5, 2018 What s In the New Hypertension Guidelines? Max C. Reif, MD, FACP Objectives: At the end of the
More informationMultiple clinical and observational studies in the elderly
Predominance of Isolated Systolic Hypertension Among Middle-Aged and Elderly US Hypertensives Analysis Based on National Health and Nutrition Examination Survey (NHANES) III Stanley S. Franklin, Milagros
More informationThe New England Journal of Medicine VITAMIN E SUPPLEMENTATION AND CARDIOVASCULAR EVENTS IN HIGH-RISK PATIENTS
VITAMIN E SUPPLEMENTATION AND CARDIOVASCULAR EVENTS IN HIGH-RISK PATIENTS THE HEART OUTCOMES PREVENTION EVALUATION STUDY INVESTIGATORS* ABSTRACT Background Observational and experimental studies suggest
More informationDiabetes Care Publish Ahead of Print, published online October 3, 2007
Diabetes Care Publish Ahead of Print, published online October 3, 2007 Relationship of polyunsaturated fatty acids (PUFA) intake to peripheral neuropathy (PN) among adults with diabetes in National Health
More informationHEART HEALTH AND HEALTHY EATING HABITS
HEART HEALTH AND HEALTHY EATING HABITS ELIZABETH PASH PENNIMAN RD,LD CLINICAL DIETITIAN Professional Member American Heart Association; Council on Nutrition, Physical Activity and Metabolism PURPOSE: Recognize
More informationSupplementary Online Content
Supplementary Online Content Song M, Fung TT, Hu FB, et al. Association of animal and plant protein intake with all-cause and cause-specific mortality. JAMA Intern Med. Published online August 1, 2016.
More informationBiases in clinical research. Seungho Ryu, MD, PhD Kanguk Samsung Hospital, Sungkyunkwan University
Biases in clinical research Seungho Ryu, MD, PhD Kanguk Samsung Hospital, Sungkyunkwan University Learning objectives Describe the threats to causal inferences in clinical studies Understand the role of
More informationObesity and Control. Body Mass Index (BMI) and Sedentary Time in Adults
Obesity and Control Received: May 14, 2015 Accepted: Jun 15, 2015 Open Access Published: Jun 18, 2015 http://dx.doi.org/10.14437/2378-7805-2-106 Research Peter D Hart, Obes Control Open Access 2015, 2:1
More informationDiversity and HTN: Approaches to optimal BP control in AfricanAmericans
Diversity and HTN: Approaches to optimal BP control in AfricanAmericans Quinn Capers, IV, MD, FACC, FSCAI Assistant Professor of Medicine Associate Dean for Admissions Do Racial Differences Really Exist
More informationHypertension with Comorbidities Treatment of Metabolic Risk Factors in Children and Adolescents
Hypertension with Comorbidities Treatment of Metabolic Risk Factors in Children and Adolescents Stella Stabouli Ass. Professor Pediatrics 1 st Department of Pediatrics Hippocratio Hospital Evaluation of
More informationAntihypertensive Drug Therapy and Survival by Treatment Status in a National Survey
1-28 Antihypertensive Drug Therapy and Survival by Treatment Status in a National Survey Richard J. Havlik, Andrea Z. LaCroix, Joel C. Kleinman, Deborah D. Ingram, Tamara Harris, and Joan Cornoni-Huntley
More informationARTICLE. Dietary Nutrients and Blood Pressure in Urban Minority Adolescents at Risk for Hypertension
ARTICLE Dietary Nutrients and Blood Pressure in Urban Minority Adolescents at Risk for Hypertension Bonita Falkner, MD; Katherine Sherif, MD; Suzanne Michel, MPH, RD; Harvey Kushner, PhD Objective: To
More informationHypertension and the SPRINT Trial: Is Lower Better
Hypertension and the SPRINT Trial: Is Lower Better 8th Annual Orange County Symposium on Cardiovascular Disease Prevention Saturday, October 8, 2016 Keith C. Norris, MD, PhD, FASN Professor of Medicine,
More informationRisk of cardiovascular events among women with high normal blood pressure or blood pressure progression: prospective cohort study
EDITORIAL by Nash 1 Division of Preventive Medicine, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, 900 Commonwealth Avenue, Boston, MA 02215, USA 2 Divisions of Preventive
More informationHypertension. Uncontrolled and Apparent Treatment Resistant Hypertension in the United States, 1988 to 2008
Hypertension Uncontrolled and Apparent Treatment Resistant Hypertension in the United States, 1988 to 2008 Brent M. Egan, MD; Yumin Zhao, PhD; R. Neal Axon, MD; Walter A. Brzezinski, MD; Keith C. Ferdinand,
More informationWhy you should take the latest sodium study with a huge grain of salt
Harvard School of Public Health The Nutrition Source Flawed Science on Sodium from JAMA Why you should take the latest sodium study with a huge grain of salt A new study would have you believe that low-salt
More informationNew insights into the effects on blood pressure of diets low in salt and high in fruits and vegetables and low-fat dairy products
New insights into the effects on blood pressure of diets low in salt and high in fruits and vegetables and low-fat dairy products The Harvard community has made this article openly available. Please share
More informationName of Policy: Measurement of Long-Chain Omega-3 Fatty Acids in Red Blood Cell Membranes as a Cardiac Risk Factor
Name of Policy: Measurement of Long-Chain Omega-3 Fatty Acids in Red Blood Cell Membranes as a Cardiac Risk Factor Policy #: 239 Latest Review Date: July 2010 Category: Laboratory Policy Grade: Active
More informationIntermediate Methods in Epidemiology Exercise No. 4 - Passive smoking and atherosclerosis
Intermediate Methods in Epidemiology 2008 Exercise No. 4 - Passive smoking and atherosclerosis The purpose of this exercise is to allow students to recapitulate issues discussed throughout the course which
More informationAlcohol consumption and blood pressure change: 5-year follow-up study of the association in normotensive workers
(2001) 15, 367 372 2001 Nature Publishing Group All rights reserved 0950-9240/01 $15.00 www.nature.com/jhh ORIGINAL ARTICLE Alcohol consumption and blood pressure change: 5-year follow-up study of the
More informationFruit and vegetable intake and risk of cardiovascular disease: the Women s Health Study 1,2
Fruit and vegetable intake and risk of cardiovascular disease: the Women s Health Study 1,2 Simin Liu, JoAnn E Manson, I-Min Lee, Stephen R Cole, Charles H Hennekens, Walter C Willett, and Julie E Buring
More informationHypertension Diagnosis and Physician Consult to Reduce Salt Intake
Hypertension Diagnosis and Physician Consult to Reduce Salt Intake Reuben William Horace II* Brown University School of Public Health, Providence, Rhode Island Research Article Received date: 10/05/2017
More informationISPUB.COM. Comparing Weight Reduction and Medications in Treating Mild Hypertension: A Systematic Literature Review. S Hamlin, T Brown BACKGROUND
ISPUB.COM The Internet Journal of Advanced Nursing Practice Volume 3 Number 2 Comparing Weight Reduction and Medications in Treating Mild Hypertension: A Systematic Literature S Hamlin, T Brown Citation
More informationImplications of The LookAHEAD Trial: Is Weight Loss Beneficial for Patients with Diabetes?
Implications of The LookAHEAD Trial: Is Weight Loss Beneficial for Patients with Diabetes? Boston, MA November 7, 213 Edward S. Horton, MD Professor of Medicine Harvard Medical School Senior Investigator
More informationORIGINAL INVESTIGATION. Deteriorating Dietary Habits Among Adults With Hypertension. DASH Dietary Accordance, NHANES and
ORIGINAL INVESTIGATION Deteriorating Dietary Habits Among Adults With Hypertension DASH Dietary Accordance, 1988-1994 and 1999-2004 Philip B. Mellen, MD, MS; Sue K. Gao, PhD, MPH; Mara Z. Vitolins, DrPH,
More informationORIGINAL INVESTIGATION. An Update on Aspirin in the Primary Prevention of Cardiovascular Disease
ORIGINAL INVESTIGATION An Update on in the Primary Prevention of Cardiovascular Disease Rachel S. Eidelman, MD; Patricia R. Hebert, PhD; Steven M. Weisman, PhD; Charles H. Hennekens, MD, DrPH Background:
More informationKnow Your Number Aggregate Report Single Analysis Compared to National Averages
Know Your Number Aggregate Report Single Analysis Compared to National s Client: Study Population: 2242 Population: 3,000 Date Range: 04/20/07-08/08/07 Version of Report: V6.2 Page 2 Study Population Demographics
More information